ASHLEY WIGINTON: Open Payments
NPI 1326310665 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 45 payments from 9 companies in 2025. Trend: 2023 $997 · 2024 $676 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $288 |
| ABBVIE INC. | 12 | $277 |
| Madrigal Pharmaceuticals | 7 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $94 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Novo Nordisk Inc | 2 | $35 |
| ORPHALAN INC | 1 | $30 |
| Intra-Sana Laboratories | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
Products named: MAVYRET, REZDIFFRA, XIFAXAN, IQIRVO, Wegovy, CUVRIOR, RELTONE 200 MG, OCALIVA.
Industry payments across TX — which companies pay providers there.
